CLNN
CleneยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CLNN Profile
Clene Inc.
A clinical-stage biopharmaceutical company that develops nanotherapeutics for the treatment of neurodegenerative diseases
6550 South Millrock Drive, Suite G50, Salt Lake City, Utah
--
Clene Inc., was founded on November 13, 2017. Clene is a clinical-stage biopharmaceutical company developing unique therapies for neurodegenerative diseases. Clene has invented a new nanotechnology drug platform for the development of new oral neurotherapeutic drugs. Clene is also bringing an ionic zinc and silver aqueous solution for antiviral and antibacterial use to the clinic.
